Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience

BACKGROUND: Chemoradiotherapy for head and neck cancer (SCCHN) is challenging in elderly, multi-morbid patients. Radioimmunotherapy (RIT) with cetuximab provides an option to enhance efficacy of radiotherapy without increased toxicity. We present a single-centre experience of RIT these patients. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Alexandra D, Bergmann, Zazie P, Garcia-Huttenlocher, Helena, Freier, Kolja, Debus, Jürgen, Münter, Marc W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002347/
https://www.ncbi.nlm.nih.gov/pubmed/21110844
http://dx.doi.org/10.1186/1758-3284-2-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002347/
https://www.ncbi.nlm.nih.gov/pubmed/21110844
http://dx.doi.org/10.1186/1758-3284-2-34

Ejemplares similares